Mount Sinai Vascular Institute Research
Mount Sinai Vascular Institute Research Division is a multi-disciplinary group focusing on investigational and post-market medical devices, novel drug therapies, and image-guided therapies. By partnering with internal and external academic partners as well as external industry partners, the Vascular Institute Research Team’s accomplishments have included clinical trials that focus on various aspects of:
- Peripheral Vascular Disease
PTA and Drug-Coated Balloon Angioplasty, Atherectomy, and Bare and Drug Stent Technology - Renal Artery Stenting
- Minimally Invasive Aortic Treatment
EVAR, TEVAR, and Complex Fenestrated Endografts - Carotid Artery Stenting and Endarterectomy
- IVC Filter, Pulmonary Embolism, and Deep Vein Thrombosis
Mount Sinai’s physicians serve as clinical investigators in these clinical trials to research new and innovative medical devices for our patients. Additionally, they share their knowledge of new devices by lecturing around the world on the latest methods of vascular disease treatment.
At the forefront of Vascular Research, Mount Sinai Vascular Institute’s Research Team has earned international acclaim through its expanding participation in research trials. The program has published more than 100 papers in peer-reviewed journals and received grant funding from various government and industry sponsors.
Our primary focus is to ensure the best care, safety, and well-being of our patients through innovative technology.
To learn more about taking part in one of our research trials, please call our research team at 305-674-2071.
BOLT: A Prospective, Multicenter Study of Patients with Deep Vein Thrombosis to Evaluate the Safety and Efficacy of the Indigo® Aspiration System (Protocol #22-02-H-01)
Have you ever been diagnosed with Deep Vein Thrombosis or DVT? If you are feeling pain when you walk, one of your vessels may have significant narrowing or blockage. The objective of this study is to demonstrate the safety and efficacy of the Indigo Aspiration system for percutaneous mechanical thrombectomy in a population presenting with obstruction due to deep vein thrombosis (DVT) who are eligible for treatment.
Please contact Yoselin Lugo or Tamar Capehart at 305-674-2071 for any questions or further information on how you can take part in The BOLT Study.